These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31747968)

  • 1. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients.
    Kasikova L; Hensler M; Truxova I; Skapa P; Laco J; Belicova L; Praznovec I; Vosahlikova S; Halaska MJ; Brtnicky T; Rob L; Presl J; Kostun J; Cremer I; Ryska A; Kroemer G; Galluzzi L; Spisek R; Fucikova J
    J Immunother Cancer; 2019 Nov; 7(1):312. PubMed ID: 31747968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.
    Truxova I; Kasikova L; Hensler M; Skapa P; Laco J; Pecen L; Belicova L; Praznovec I; Halaska MJ; Brtnicky T; Salkova E; Rob L; Kodet R; Goc J; Sautes-Fridman C; Fridman WH; Ryska A; Galluzzi L; Spisek R; Fucikova J
    J Immunother Cancer; 2018 Dec; 6(1):139. PubMed ID: 30526667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer.
    Fucikova J; Rakova J; Hensler M; Kasikova L; Belicova L; Hladikova K; Truxova I; Skapa P; Laco J; Pecen L; Praznovec I; Halaska MJ; Brtnicky T; Kodet R; Fialova A; Pineau J; Gey A; Tartour E; Ryska A; Galluzzi L; Spisek R
    Clin Cancer Res; 2019 Aug; 25(15):4820-4831. PubMed ID: 31076549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.
    Hensler M; Kasikova L; Fiser K; Rakova J; Skapa P; Laco J; Lanickova T; Pecen L; Truxova I; Vosahlikova S; Moserova I; Praznovec I; Drochytek V; Rehackova M; Brtnicky T; Rob L; Benes V; Pistolic J; Sojka L; Ryska A; Sautes-Fridman C; Fridman WH; Galluzzi L; Spisek R; Fucikova J
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32819974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
    McCool KW; Freeman ZT; Zhai Y; Wu R; Hu K; Liu CJ; Tomlins SA; Fearon ER; Magnuson B; Kuick R; Cho KR
    Cancer Res; 2020 Feb; 80(4):877-889. PubMed ID: 31806642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death.
    Kasikova L; Truxova I; Cremer I; Sautes-Fridman C; Kepp O; Kroemer G; Spisek R; Fucikova J
    Methods Enzymol; 2020; 632():15-25. PubMed ID: 32000894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calreticulin, a potential coregulator of immune checkpoints and biomarker associated with tumor microenvironment and clinical prognostic significance in breast invasive carcinoma.
    Lin J; Chen Y; Zhang Z; Qi F; Zhang M
    Environ Toxicol; 2024 May; 39(5):2717-2731. PubMed ID: 38247288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
    Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+ T-lymphocytes predicts disease-free survival.
    Bansal A; Srinivasan R; Rohilla M; Rai B; Rajwanshi A; Suri V; Chandra Saha S
    APMIS; 2021 May; 129(5):254-264. PubMed ID: 33455015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of immunogenic chemotherapy by artificially controlled calreticulin secretion from tumor cells.
    Zhao L; Zhang S; Chen H; Kroemer G; Kepp O; Liu P
    Methods Cell Biol; 2022; 172():99-114. PubMed ID: 36064229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis.
    Kepp O; Liu P; Zhao L; Plo I; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1792037. PubMed ID: 32923154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.
    Ardighieri L; Missale F; Bugatti M; Gatta LB; Pezzali I; Monti M; Gottardi S; Zanotti L; Bignotti E; Ravaggi A; Tognon G; Odicino F; Calza S; Missolo-Koussou Y; Ries CH; Helft J; Vermi W
    Front Immunol; 2021; 12():690201. PubMed ID: 34220848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
    Vera CA; Oróstica L; Gabler F; Ferreira A; Selman A; Vega M; Romero CA
    Int J Oncol; 2017 Apr; 50(4):1261-1270. PubMed ID: 28260038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.
    Kotrbová A; Ovesná P; Gybel' T; Radaszkiewicz T; Bednaříková M; Hausnerová J; Jandáková E; Minář L; Crha I; Weinberger V; Záveský L; Bryja V; Pospíchalová V
    Theranostics; 2020; 10(2):537-552. PubMed ID: 31903136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy.
    Lo CS; Sanii S; Kroeger DR; Milne K; Talhouk A; Chiu DS; Rahimi K; Shaw PA; Clarke BA; Nelson BH
    Clin Cancer Res; 2017 Feb; 23(4):925-934. PubMed ID: 27601594
    [No Abstract]   [Full Text] [Related]  

  • 16. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis.
    Fucikova J; Becht E; Iribarren K; Goc J; Remark R; Damotte D; Alifano M; Devi P; Biton J; Germain C; Lupo A; Fridman WH; Dieu-Nosjean MC; Kroemer G; Sautès-Fridman C; Cremer I
    Cancer Res; 2016 Apr; 76(7):1746-56. PubMed ID: 26842877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens.
    Liu X; Song N; Liu Y; Liu Y; Li J; Ding J; Tong Z
    Cell Immunol; 2015 Jun; 295(2):77-82. PubMed ID: 25863743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer.
    Yang H; Yu M; Zhong S; You Y; Feng F
    J Ovarian Res; 2022 Jan; 15(1):18. PubMed ID: 35093146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.
    Koti M; Siu A; Clément I; Bidarimath M; Turashvili G; Edwards A; Rahimi K; Mes-Masson AM; Squire JA
    Br J Cancer; 2015 Mar; 112(7):1215-22. PubMed ID: 25826225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calreticulin and cancer.
    Fucikova J; Spisek R; Kroemer G; Galluzzi L
    Cell Res; 2021 Jan; 31(1):5-16. PubMed ID: 32733014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.